Business Wire

Ant International Deepens Payment and Digitalisation Ecosystem with AI-Driven Embedded Finance Solutions in Year of Transformation

6.12.2024 17:00:00 CET | Business Wire | Press release

Share

Numbers show Alipay+ expands a vibrant wallet-based payment and digitalisation space that further strengthens WorldFirst and Antom, the two business fintech services.Starting with over 11 million underserved SMEs and individuals in Southeast Asia and South Asia, the new Embedded Finance segment deepens Ant International’s ecosystem by offering a rich array of FX, treasury management, inclusive lending and other AI-powered fintech solutions to clients and partners across the other three main businesses.

With a series of organisational and strategic upgrades in 2024, Ant International, a leading global digital payment and financial technology provider, reported robust growth over the past year among all its four pillar businesses, Alipay+, Antom, WorldFirst and Embedded Finance.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205425502/en/

(Graphic: Business Wire)

Alipay+ expanded its vibrant wallet-based payment and digitalisation space that further strengthens WorldFirst and Antom, the two business fintech services. The new Embedded Finance segment deepens Ant International's ecosystem by offering a rich array of FX, treasury management, inclusive lending and other AI-powered fintech solutions to clients and partners across the other three main businesses.

“2024 has been a transformative year for Ant International,” said Peng Yang, Chief Executive Officer of Ant International. “We are committed to advance inclusive growth through AI-powered innovation and collaboration on cross-border travel, trade, commerce and inclusive finance.”

Based in Singapore, Ant International provides partners across industries and markets a comprehensive range of digital payment and financial technology solutions. It is committed to driving inclusive growth through open collaboration and continuous innovation.

Among Ant International's notable progresses in 2024 so far:

Alipay+: Ant International’s cross-border mobile payment and digitalisation technology solutions.

  • Alipay+ leads the industry in collaboration with 35 leading mobile payment partners, including e-wallets, banking apps and BNPL apps, etc., connecting over 90 million merchants in 66 markets to 1.6 billion user accounts. It has also formed strategic partnerships with national standardised QR schemes, such as Singapore’s SGQR, Malaysia’s PayNet, South Korea’s ZeroPay, Cambodia's KHQR, Nepal’s NepalPay QR and Sri Lanka's LankaPay.
  • Among the global merchants accepting QR code payments via Alipay+, over 90% are SMEs, reflecting Ant International’s focus on inclusive digital transformation.
  • Cross-border transactions of global payment partners together (excluding Alipay) via Alipay+ registered three times year-on-year increase in 2024, where Alipay maintains the leadership.

Alipay+ builds a broader digital payment and digitalisation ecosystem for other pillar businesses of Ant International.

Antom: a leading merchant payment and digitisation services provider, offering one-stop, vertical-specific digital payment solutions to merchants of all sizes.

  • Total payment volume (TPV) of Antom’s direct acquiring services nearly doubled between January and November 2024 over same period of 2023.
  • Antom continues to strengthen its payment processing capabilities across all payment channels. Antom’s card processing volume grew over 10 times from that of previous year, while delivering top notch authorization rates to its global enterprise merchants.
  • Antom continues to launch tech-driven innovative solutions to provide more secure and efficient services at lower cost to its customers. Antom Copilot helped enhance operational efficiency for merchants by reducing the payment channel integration time from 5 to 10 days to only a few minutes. Antom EasySafePay streamlined digital wallet payments procedures, eliminating the need to redirect from merchant checkout page to the user’s wallet app, and offers full account takeover protection to wallet users, and lead to significant payment success rate increase.

WorldFirst: a one-stop digital payment and financial services platform for global businesses.

  • In 2024, five years after its acquisition, WorldFirst achieved an annual TPV of US$100 billion, four times that of 2020. This marks its transformation into the world's leading one-stop digital payment and financial services platform for cross-border businesses.
  • Accumulatively, WorldFirst has served more than 1 million SMEs globally, with a total TPV surpassing US$300 billion and an ever-strengthening growth momentum as it expands footprints from Asia and Europe to the rest of the world.

Under Embedded Finance, our Credit Tech and Platform Tech teams leverage cutting-edge AI and blockchain technologies to innovate secure, end-to-end embedded finance solutions to clients and partners across Alipay+, Antom and WorldFirst businesses, ranging from risk-modelling, cross-border settlement, FX and liquidity management, to credit and lending services for underserved SMEs and individuals.

  • In line with G20's commitment to lower cross-border payment costs via technology innovation, Platform Tech developed a world-leading Time-Series Transformer AI FX Model to help multi-national merchants in airline, e-commerce and other sectors to improve treasury management efficiency and reduce cost. Our FX solutions predict real-time local currency needs by the hour, with an accuracy of over 90%, significantly lowering cost and uncertainty for not only our own operations but millions of merchants, including SMEs.

Through collaborative innovation with global financial institutions, we leverage blockchain technology to provide 24/7 real-time cross-border settlement serviceability to our global business and clients. In 2024, the blockchain solution supported over one third of Ant International's total processing volume.

  • In 2024, leveraging AI-powered Credit Tech and Risk Tech capabilities, Ant International added to ANEXT Bank, its Singapore-based MSME-focused digital bank, a new inclusive credit service under the brand bettr. Today in emerging markets including Bangladesh and Indonesia, bettr collaborates with local fintech partners to enable over 11 million unserved micro businesses and individuals, most first-time borrowers, to acquire uncollateralized loan services based on more accurate and fairer credit ratings.
  • In 2024, loans under management across Ant International's SME financing services more than doubled compared to 2023.

“In 2025, we will continue to be laser-focused on supporting SMEs across borders with AI-powered innovative and trusted payment, digitalisation, and inclusive financing solutions through expanded public- and private-sector collaboration,” said Yang.

About Ant International
Headquartered in Singapore, Ant International powers the future of global commerce with digital innovation for everyone and every business to thrive. In close collaboration with partners, we support merchants of all sizes worldwide to realize their growth aspirations through a comprehensive range of tech-driven digital payment and financial services solutions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241205425502/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye